Cargando…
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Within the past decade, the field of immunotherapy has revolutionized the treatment of many cancers with the development and regulatory approval of various immune-checkpoint inhibitors and chimeric antigen receptor T cell therapies in diverse indications. Another promising approach to cancer immunot...
Autores principales: | Blass, Eryn, Ott, Patrick A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816749/ https://www.ncbi.nlm.nih.gov/pubmed/33473220 http://dx.doi.org/10.1038/s41571-020-00460-2 |
Ejemplares similares
-
Personalized cancer neoantigen vaccines come of age
por: Chu, Yanhong, et al.
Publicado: (2018) -
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022) -
The perfect personalized cancer therapy: cancer vaccines against neoantigens
por: Aurisicchio, Luigi, et al.
Publicado: (2018) -
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
por: Ding, Zhenyu, et al.
Publicado: (2021) -
Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives
por: Chen, Xiaotong, et al.
Publicado: (2020)